期刊文献+

重庆市体检人群脂肪肝患病率及影响因素分析 被引量:42

Analysis of the prevalence of fatty liver and its related risk factors in physical examination group of Chongqing
下载PDF
导出
摘要 目的:了解重庆市体检人群脂肪肝的患病率,分析其影响因素。方法:对我院健康体检的13610名人员中脂肪肝患者的体重指数、血压、血脂、血糖、肝功能等检测结果与非脂肪肝组进行对比分析。结果:脂肪肝的检出率为16.9%,男性明显高于女性,约是女性的2.6倍,随着年龄的增长,脂肪肝的患病率增加。脂肪肝组的体重指数BMI、血压BP、血脂TG、TC、血糖FBG及转氨酶ALT、AST水平与非脂肪肝组比较差异有显著性。脂肪肝组中合并肥胖、血脂异常、高血压、糖尿病的患病率显著高于非脂肪肝组。两组间乙肝病毒携带者的比例无差异。结论:肥胖、糖尿病、血脂异常、高血压是脂肪肝发病的危险因素,脂肪肝可表现为转氨酶轻-中度的升高。减轻体重,控制高血脂和维持正常的血糖及血压水平是防治脂肪肝的重要措施。 Objective:To determine the prevalence of fatty hver in physical examination group of Chongqing,and to analyze its risk factors.Methods:Total 13610 persons who underwent physical examination and laboratory tests,were measured the level of body mass index(BMI),blood pressure(BP),blood lipids(TC&TG),glucose (FBG)and liver function(ALT&AST).The results of cases of fatty liver were compared with those of non-fatty liver.Results:The ratio of fatty liver was16.9%,and the prevalence of fatty liver in male was significantly higher(22.4%) than that of in females( 8.69% ) , about 2.6 times.The prevalence of fatty liver was increased with age.There was significant difference between the fatty liver and non-fatty liver groups in their BMI,BP,TC, TG,FBG,ALT and AST.The morbidity of obesity,dyslipidemia,hypertention,and diabetes mellitus in the fatty liver group were significantly higher than in non-fatty liver.The ratio of hepatitis B cartier was no significant difference between the two groups. Conclusion:Obesity,diabetes mellitus,hyperlipidemia and hypertention may be independent risk factors of fatty liver. The mildly to moderate abnormal hepatic functions could be found in patients with fatty liver.To lose the body weight,control the hyperlipidemia and maintain normal glucose,blood pressure are important measures to prevent the fatty liver.
出处 《重庆医科大学学报》 CAS CSCD 2007年第2期169-172,共4页 Journal of Chongqing Medical University
关键词 脂肪肝 健康体检 危险因素 Fatty liver Physical examination Risk factor
  • 相关文献

参考文献18

  • 1Angulo P.Nonaleoholie fatty liver disease[J].N Engl J Med,2002;346:1221-1231. 被引量:1
  • 2Lonardo A.Fatty liver and nonalcoholic steatohepatitis.Where do we stand and where are we goin[J].Dig Dis,1999;17:80-89. 被引量:1
  • 3Sheth SG,Gordon FP,Chopm S.Nonalcoholic Steatohepatitis[J].Ann Intern Med, 1997; 126:137-145. 被引量:1
  • 4Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association.Diagnostic criteria of nonalcoholic fatty liver Disease[S].Zhonghua Ganzangbing Zazhi, 2003 ; 11 : 71. 被引量:1
  • 5Dam-Larsen S,Franzmann M,Andersen IB,et al.Long term prognosis of fatty liver:risk of chronic liver disease and death[J].Gut, 2004; 53 : 750-755. 被引量:1
  • 6Adams LA,Sanderson S,Lindor KD,et al.The histological course of nonalcoholic fatty liver disease:a longitudinal study of 103 patients with sequential liver biopsies[J].J Hepatol, 2005 ; 42:132-138. 被引量:1
  • 7Marrero JA,Fontana RJ,Su GL,et al.NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States[J].Hepatology,2002 ; 36:1349-1354. 被引量:1
  • 8Joseph AE,Saverymuttu SH,al-Sam S,et al.Comparison of liver histology with ultrasonography in assessing diffuse parenehymal liver disease[J].Clin Radiol, 1991 ;43:26-31. 被引量:1
  • 9Hultcrantz R,Gabrielsson N.Patients with persistent elevation ofaminotransferases:Investigation with ultrasonography,radionuclide imaging and liver biopsy[J]J Intern Med,1993;233:7-12. 被引量:1
  • 10Browning J,Szczepaniak L,Dobbins R,et al.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity[J].Hepatology, 2004; 40:1387-1395. 被引量:1

二级参考文献26

  • 1范建高 曾民德 等.上海市4009名机关职员脂肪肝流行病学调查[J].中华肝脏病杂志,1998,6(1):17-17. 被引量:34
  • 2Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies. Gastroenterology, 2003, 124:248-250. 被引量:1
  • 3Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1705-1725. 被引量:1
  • 4Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology, 2004, 39: 476-483. 被引量:1
  • 5Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med,2000, 132: 112-117. 被引量:1
  • 6Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 2002, 17:1098-1105. 被引量:1
  • 7周永昌 郭万学.超声医学[M](第3版)[M].北京:北京科学技术文献出版社,1997.793. 被引量:12
  • 8MARCHESINI G, BRIZI M, MORSELLI-LABATE AM, et al.Association of nonalcoholic fatty liver disease with insulin resistance[J]. AM J Med, 1999, 107(5): 450-455. 被引量:1
  • 9范建高,曾民德,范竹萍,沈镭,陈政绩,李继强,邱德凯.脂肪肝患者临床特点初步探讨[J].中国实用内科杂志,1998,18(1):37-38. 被引量:42
  • 10范建高,曾民德,李继强,沈镭,陈政绩,罗国豪,刘天舒.脂肪肝的危险因素分析[J].中华预防医学杂志,1998,32(3):189-189. 被引量:57

共引文献596

同被引文献349

引证文献42

二级引证文献259

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部